글로벌 연구동향
방사선종양학
- 2017년 05월호
[Radiat Oncol.] Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.순천향의대 / 박영희, 김희정, 장아람*
- 출처
- Radiat Oncol.
- 등재일
- 2017 Apr 5
- 저널이슈번호
- 12(1):66. doi: 10.1186/s13014-017-0803-2.
- 내용
Abstract
BACKGROUND:
To evaluate the incidence of chest wall toxicity after lung stereotactic ablative radiotherapy (SABR) and identify risk factors for the development of rib fracture.
METHODS:
Thirty-nine patients with 49 lesions underwent SABR for primary or metastatic lung tumors using Cyberknife® with tumor tracking systems. Patient characteristics, treatment factors and variables obtained from dose-volume histograms (DVHs) were analyzed to find the association with chest wall toxicity. Four-dimensional (4D) dose calculations were done to investigate the effect of respiratory motion on dose to the ribs.
RESULTS:
After follow-up of median 26.7 months (range: 8.4 - 80.0), 8 patients (20.5%) experienced rib fractures and among these patients, three (37.5%) had chest wall pain at 2-3 months after SABR. Median time to rib fracture was 13.4 months (range: 8.0 - 38.5) and the 2-year actuarial risk of rib fracture was 12.2%. Dose to the 4.6 cc of the ribs (D4.6cc) and rib volume received 160 Gy or more (V160) were significant predictor for rib fracture. No significant differences between three-dimensional (3D) and 4D dose calculations were found.
CONCLUSIONS:
Parameters from DVH are useful in predicting the risk of chest wall toxicity after SABR for lung tumors. Efforts should be made to reduce the risk of the rib fracture after lung SABR.
Author information
Park Y1, Kim HJ1, Chang AR2.
1 Department of Radiation Oncology/CyberKnife Center, Soonchunhyang University Seoul Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul, 140-743, Republic of Korea.
2 Department of Radiation Oncology/CyberKnife Center, Soonchunhyang University Seoul Hospital, 59 Daesagwan-ro, Yongsan-gu, Seoul, 140-743, Republic of Korea. changaram@schmc.ac.kr.
- 키워드
- 4D dose calculation; Chest wall toxicity; Dose-volume histogram; Lung tumor; Rib fracture; Stereotactic ablative radiotherapy
- 덧글달기
- 이전글 [Radiother Oncol.] Individual case review in a phase 3 randomized trial to investigate the role of internal mammary lymph node irradiation for breast cancer: Korean Radiation Oncology Group 08-06 study.
- 다음글 [Radiother Oncol.] Novel recursive partitioning analysis classification for newly diagnosed glioblastoma: A multi-institutional study highlighting the MGMT promoter methylation and IDH1 gene mutation status.